[
  {
    "ts": "2025-12-08T03:08:54+00:00",
    "headline": "What Analysts Think Is Shifting The Story For Treace Medical Concepts Now",
    "summary": "Treace Medical Concepts' latest narrative update has left the fair value estimate steady at roughly $5.47 per share, even as the discount rate has edged down from about 8.65% to 8.60% and revenue growth expectations hold near 2.10% a year. This subtle shift reflects analysts weighing a solid Q3 top line against questions over how much of the strength was one time distributor demand versus sustainable, organic momentum in a choppy MedTech backdrop. Read on to see why these moving parts matter...",
    "url": "https://finance.yahoo.com/news/analysts-think-shifting-story-treace-030854029.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "de56cfc3-344a-31ac-8880-516c88648c7f",
      "content": {
        "id": "de56cfc3-344a-31ac-8880-516c88648c7f",
        "contentType": "STORY",
        "title": "What Analysts Think Is Shifting The Story For Treace Medical Concepts Now",
        "description": "",
        "summary": "Treace Medical Concepts' latest narrative update has left the fair value estimate steady at roughly $5.47 per share, even as the discount rate has edged down from about 8.65% to 8.60% and revenue growth expectations hold near 2.10% a year. This subtle shift reflects analysts weighing a solid Q3 top line against questions over how much of the strength was one time distributor demand versus sustainable, organic momentum in a choppy MedTech backdrop. Read on to see why these moving parts matter...",
        "pubDate": "2025-12-08T03:08:54Z",
        "displayTime": "2025-12-08T03:08:54Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qYSQ6AG4c18KIEG8bfQS1g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mH32bjf22B8VXoaGCZudBg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/analysts-think-shifting-story-treace-030854029.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/analysts-think-shifting-story-treace-030854029.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TMCI"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]